2019
DOI: 10.1128/aac.01041-19
|View full text |Cite
|
Sign up to set email alerts
|

Efflux-Mediated Resistance to New Oxazolidinones and Pleuromutilin Derivatives in Escherichia coli with Class Specificities in the Resistance-Nodulation-Cell Division-Type Drug Transport Pathways

Abstract: A major contribution of the resistance-nodulation-cell division (RND)-transporter AcrB to resistance to oxazolidinones and pleuromutilin derivatives in Escherichia coli was confirmed. However, we discovered significant differences in efflux inhibitor activities, specificities of the homologous pump YhiV (MdtF), and the impact of AcrB pathway mutations. Particularly, entrance channel double-mutation I38F I671T and distal binding pocket mutation F615A revealed class-specific transport routes of oxazolidinones an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 19 publications
0
9
0
Order By: Relevance
“…In order to explore RND-type substrate pathway specificities of GEP and ZOL versus FQs, we examined the impact of AcrB porter domain mutations with known effects on the susceptibilities to other drugs. Among distal binding pocket (DB) mutations, the highest FQ susceptibility increases were achieved by F610A, which has been known to seriously impair resistance to almost all AcrB substrates except linezolid and sutezolid (14,15). Remarkably, F610A also results in significant MIC decreases of GEP but not of ZOL.…”
mentioning
confidence: 99%
“…In order to explore RND-type substrate pathway specificities of GEP and ZOL versus FQs, we examined the impact of AcrB porter domain mutations with known effects on the susceptibilities to other drugs. Among distal binding pocket (DB) mutations, the highest FQ susceptibility increases were achieved by F610A, which has been known to seriously impair resistance to almost all AcrB substrates except linezolid and sutezolid (14,15). Remarkably, F610A also results in significant MIC decreases of GEP but not of ZOL.…”
mentioning
confidence: 99%
“…CARD analysis indicated that the antibiotic resistance of JSTW mainly comes from the efflux pump mechanism. One of the most critical is the drug‐resistant nodular cell division (RND) antibiotic efflux pump mechanism, which is the most common in Gram‐negative bacteria [37], including ade G, ade C, Tri C, mex T, sme D, cme A, and acr D. These genes can pump tetracycline antibiotics, fluoroquinolone antibiotics, triclosan, phenol antibiotics, diaminopyrimidine antibiotics, macrolide antibiotics, cephalosporins, macrolide antibiotics, fusidic acid, and aminoglycoside antibiotics. JSTW also harbors ATP binding cassette (ABC) antibiotic efflux pumps, including Tae A and msb A, which confer resistance to pleuromutilin antibiotics and nitroimidazole antibiotic.…”
Section: Resultsmentioning
confidence: 99%
“…The oxazolidinone class of antimicrobials, which includes LZD, exhibited excellent effects against gram-positive bacteria, but showed poor activity against gram-negative bacteria such as Escherichia coli, primarily due to the enhanced activity of AcrB, a RND-type efflux pump (Schumacher et al, 2007;Schuster et al, 2019). However, whether efflux pumps have a role in the resistance of gram-positive bacteria to LZD or RZD remains uncertain.…”
Section: Discussionmentioning
confidence: 99%